SCHEMBL25436706

SCHEMBL25436706

CCN(C)C(=O)C(=O)c1c[nH]c2ccc(OC)c(C)c12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ HTR1A P08908 1/20 0.38
▸ LMNA P02545 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ HIF1A Q16665 1/20 0.36
▸ CDK4 P11802 1/20 0.35
▸ CCND1 P24385 1/20 0.35
▸ CTNNB1 P35222 1/20 0.35
▸ WNT3A P56704 1/20 0.35
▸ GABRP O00591 1/20 0.35
▸ GABRD O14764 1/20 0.35
▸ GABRA1 P14867 1/20 0.35
▸ GABRB1 P18505 1/20 0.35
▸ GABRG2 P18507 1/20 0.35
▸ GABRB3 P28472 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25747852 0.87 MAPK14 (0.39) ALDH1A1HTR1ALMNAMAPTHIF1A
SCHEMBL31077729 0.87 MAPK14 (0.39) ALDH1A1HTR1ALMNAMAPTHIF1A
SCHEMBL25423289 0.87 HTR1A (0.50) ALDH1A1MEN1CYP1A2CYP2C9CYP2C19
SCHEMBL25747868 0.85 MEN1 (0.36) ALDH1A1MEN1CYP1A2CYP2C9CYP2C19
SCHEMBL25436274 0.83 ALDH1A1 (0.38) ALDH1A1MEN1CYP1A2CYP2C9CYP2C19
SCHEMBL25747864 0.83 HTR1A (0.35) ALDH1A1HTR1ALMNAMAPTHIF1A
SCHEMBL25748328 0.81 NR4A2 (0.36) ALDH1A1MEN1CYP1A2CYP2C9CYP2C19
SCHEMBL25289183 0.79 GABRP (0.41) MEN1KMT2ALMNAMAPTGABRP
SCHEMBL31077662 0.79 GABRP (0.41) MEN1KMT2ALMNAMAPTGABRP
SCHEMBL17417724 0.77 PRKAB2 (0.46) ALDH1A1CYP1A2MAPTMTNR1AMTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250101038-A1 COMPOUNDS Psylo Pty Ltd (AU) 2025-03-27 — — US disclosed
EP-4452937-A1 COMPOUNDS Psylo Pty Ltd (AU) 2024-10-30 — — EP disclosed
CN-118715204-A Compounds of formula (I) 普赛洛私人有限公司 2024-09-27 — — CN disclosed
WO-2023115166-A1 COMPOUNDS Psylo Pty Ltd (AU) 2023-06-29 — — WO disclosed
WO-2023115166-A1 COMPOUNDS Psylo Pty Ltd (AU) 2023-06-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250101038-A1 COMPOUNDS NLN, SLC18A2, PYGB ALDH1A1 981/4885MEN1 1401/4885CYP1A2 442/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback